Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2023-10-05 | 2024-07-03 | 206407 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110709 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-09-05 | 2019-10-04 | 93137 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-17 | 2024-11-28 | 240522 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-06-18 | 2019-07-31 | 86902 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-08-18 | 2023-07-21 | 167209 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-01-27 | 2022-03-18 | 153730 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-02-29 | 2024-12-19 | 220986 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-05 | 2021-02-25 | 133476 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-05-12 | 2022-09-08 | 160445 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-09-23 | 2021-10-28 | 146095 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-25 | 2021-07-15 | 134746 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-04-11 | 2024-10-17 | 224886 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-12-19 | 2025-03-27 | 246104 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2025-02-13 | 2025-12-11 | 250393 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |